Li C - Search Results

1

Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair.

Zhang D, Zhang F, Zhang Y, Gao X, Li C, Yang N, Cao K. Zhang D, et al. Among authors: li c. Transpl Int. 2007 Feb;20(2):174-83. doi: 10.1111/j.1432-2277.2006.00407.x. Transpl Int. 2007. PMID: 17239026 Free article.

2

Clinical cellular cardiomyoplasty: technical considerations.

Zhang F, Yang Z, Chen Y, Qin J, Zhu T, Xu D, Xu Z, Xu Q, Qian Y, Ma W, Chen L, Gao X, Li C, Ha T, Kao RL. Zhang F, et al. Among authors: li c. J Card Surg. 2003 May-Jun;18(3):268-73. doi: 10.1046/j.1540-8191.2003.02043.x. J Card Surg. 2003. PMID: 12809404

3

Cellular cardiomyoplasty: a preliminary clinical report.

Zhang F, Gao X, Yiang ZJ, Ma W, Li C, Kao RL. Zhang F, et al. Among authors: li c. Cardiovasc Radiat Med. 2003 Jan-Mar;4(1):39-42. doi: 10.1016/s1522-1865(03)00116-1. Cardiovasc Radiat Med. 2003. PMID: 12892772

4

Cellular cardiomyoplasty for a patient with heart failure.

Zhang F, Chen Y, Yang Z, Gao X, Ma W, Li C, Kao RL. Zhang F, et al. Among authors: li c. Cardiovasc Radiat Med. 2003 Jan-Mar;4(1):43-6. doi: 10.1016/s1522-1865(03)00111-2. Cardiovasc Radiat Med. 2003. PMID: 12892773

5

Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection.

Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W, Williams DL. Li C, et al. Cardiovasc Res. 2004 Feb 15;61(3):538-47. doi: 10.1016/j.cardiores.2003.09.007. Cardiovasc Res. 2004. PMID: 14962484

6

Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo.

Ha T, Hua F, Li Y, Ma J, Gao X, Kelley J, Zhao A, Haddad GE, Williams DL, Browder IW, Kao RL, Li C. Ha T, et al. Among authors: li c, li y. Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H985-94. doi: 10.1152/ajpheart.00720.2005. Epub 2005 Sep 30. Am J Physiol Heart Circ Physiol. 2006. PMID: 16199478 Free article.

7

Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts.

Hua F, Ha T, Ma J, Gao X, Kelley J, Williams DL, Browder IW, Kao RL, Li C. Hua F, et al. Among authors: li c. Biochem Biophys Res Commun. 2005 Dec 16;338(2):1118-25. doi: 10.1016/j.bbrc.2005.10.068. Epub 2005 Oct 21. Biochem Biophys Res Commun. 2005. PMID: 16259957

8

Erythropoietin enhances the angiogenic potency of autologous bone marrow stromal cells in a rat model of myocardial infarction.

Zhang D, Zhang F, Zhang Y, Gao X, Li C, Ma W, Cao K. Zhang D, et al. Among authors: li c. Cardiology. 2007;108(4):228-36. doi: 10.1159/000096803. Epub 2006 Nov 9. Cardiology. 2007. PMID: 17106196

9

[Erythropoietin enhances the therapy potency of autologous bone marrow stromal cells in a rat heart infarction model via phosphatidylinositol-3-kinase/Akt pathway].

Zhang DG, Zhang FM, Zhang YQ, Zhou F, Gao X, Li CF, Cao KJ. Zhang DG, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):912-6. Zhonghua Xin Xue Guan Bing Za Zhi. 2006. PMID: 17217721 Chinese.

10

Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium.

Liu X, Chen Y, Zhang F, Chen L, Ha T, Gao X, Li C. Liu X, et al. Among authors: li c. Scand Cardiovasc J. 2007 Apr;41(2):95-101. doi: 10.1080/14017430701197593. Scand Cardiovasc J. 2007. PMID: 17454834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83,541 results

Search Page